SUPPRESSION OF THE LUTEINIZING HORMONE RELEASING EFFECT OF LUTEINIZING HORMONE RELEASING HORMONE BY ARGININE-VASOTOCIN IN IMMATURE MALE DOGS

in Journal of Endocrinology
Authors:
K. YAMASHITA
Search for other papers by K. YAMASHITA in
Current site
Google Scholar
PubMed
Close
,
M. MIENO
Search for other papers by M. MIENO in
Current site
Google Scholar
PubMed
Close
, and
ER. YAMASHITA
Search for other papers by ER. YAMASHITA in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

Arginine-vasotocin (0·1 or 10 ng/kg body wt) was administered into the carotid artery of anaesthetized immature male dogs 3 h before the administration of a standard dose of luteinizing hormone releasing hormone (LH-RH, 5 μg/kg body wt) into the same vessel. The rate of secretion of 17-oxosteroids by the testes in vivo served as an index of luteinizing hormone (LH) secretion. The administration of LH-RH into the carotid artery of control dogs which had been injected with isotonic saline caused a slight but definite increase in the secretion of testicular 17-oxosteroids. This effect of LH-RH on the testicular secretion of steroids was markedly reduced by pretreatment with arginine-vasotocin. However, the testicular response to the i.v. administration of human chorionic gonadotrophin (5 i.u./kg body wt) was unaffected by pretreatment with arginine-vasotocin (10 ng/kg body wt). These results indicate that in immature male dogs, arginine-vasotocin is able to inhibit the action of LH-RH by acting directly on the anterior pituitary gland.

 

  • Collapse
  • Expand